VIP (Vasoactive Intestinal Peptide)

Vasoactive Intestinal Peptide (VIP) is a pleiotropic neuropeptide initially isolated from porcine duodenum. Its primary structure consists of 28 amino acids, characterized by its amphiphilic nature. VIP is synthesized as part of a larger precursor protein, prepro-VIP, which undergoes proteolytic cleavage to yield the mature peptide. The molecular structure of VIP features a high degree of conservation across species, highlighting its fundamental biological importance. Research into VIP began with its discovery in the early 1970s, identifying its potent vasodilatory properties. Subsequent investigations revealed its widespread distribution and multifaceted roles, including neurotransmission, immunomodulation, and regulation of various physiological processes. VIP exerts its effects primarily through two G protein-coupled receptors, VPAC1 and VPAC2, which are differentially expressed in various tissues and cell types, leading to distinct cellular responses upon ligand binding. In laboratory settings, VIP is a valuable tool for investigating neurophysiological processes, including synaptic transmission, neuronal plasticity, and neuroprotection. Its involvement in inflammatory responses and immune regulation makes it relevant for studies on neuroinflammation and immune-mediated disorders. Furthermore, VIP's role in smooth muscle relaxation and glandular secretion provides avenues for research into cardiovascular physiology and exocrine function. Researchers utilize synthetic VIP to explore receptor pharmacology, signal transduction pathways, and the peptide's potential as a modulator of cellular activity in diverse biological systems.